Diseases, Conditions, Syndromes

Positive results for Lilly and Regeneron COVID antibodies

US pharmaceutical company Eli Lilly's combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in high-risk patients with recent positive tests, the company said Tuesday.

Medications

FDA launches first app to identify drug shortages

(HealthDay)—A mobile phone application (app) has been released to identify current drug shortages, resolved shortages, or discontinuations of drug products, according to a press release published by the U.S. Food and Drug ...

Medical research

Experimental stem cell treatment leaves three women blind

An experimental treatment - which blinded three women after stem cells from abdominal fat were injected into their eyes - was advertised on a government-run clinical trial website but lacked proper safeguards, researchers ...

Pediatrics

How many children are at risk of measles in the United States?

Despite the MMR vaccine controversy resulting from a series of now discredited studies linking the vaccine with autism, childhood vaccination rates remain high in the United States. In 2013, 92% of children aged 19 to 35 ...

Other

Pfizer lifts outlook as COVID-19 vaccine drives results

Pfizer again boosted its 2021 profit and revenue outlook on Tuesday, bolstered by the latest surge in COVID-19 vaccinations, including regulatory approvals for boosters and shots for younger children.

Medical economics

J&J buys medical robotics company for $3.4 bn

US healthcare and consumer products giant Johnson & Johnson announced Wednesday it will acquire medical robotics company Auris Health for $3.4 billion, arguing the technology will become more central to surgery.

page 7 from 10